We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antibodies of SARS-survivors Mimic Membranes to Trick Viruses

News   Feb 01, 2019 | Original story from the University of Washington

 
Antibodies of SARS-survivors Mimic Membranes to Trick Viruses

An artist's conception of antibody functional mimicry shows a mime at a mirror. Whereas his hand holds SARS-CoV S bound to an ACE2 cell receptor (teal), his reflection shows a SARS-CoV S bound to the neutralizing antibody fragment S230 (purple). Image credit: Jon Klein

 
 
 

RELATED ARTICLES

Therapeutic Approach to Tackle African Sleeping Sickness

News

A small inhibitor molecule inhibits parasitic enzyme. This novel concept could also be employed in the future rational design of drugs for the treatment of other diseases.

READ MORE

Type 1 Diabetes Could Be Triggered by Viruses That Linger in the Gut

News

Researchers provide new evidence supporting an association between elevated levels of enteroviruses in the intestinal tracts of children and islet autoimmunity, a precursor to Type 1 diabetes.

READ MORE

A Way to Improve Cancer Immunotherapy?

News

A new study has identified a drug that potentially could make a common type of immunotherapy for cancer even more effective. The study in laboratory mice found that the drug dasatinib, which is FDA-approved to treat certain types of leukemia, greatly enhances responses to a form of immunotherapy that is used against a wide range of other cancers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE